Coverart for item
The Resource The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary, Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies

The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary, Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies

Label
The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary
Title
The public health emergency medical countermeasures enterprise
Title remainder
innovative strategies to enhance products from discovery through approval : workshop summary
Statement of responsibility
Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Contributor
Subject
Genre
Language
eng
Summary
"During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE--a partnership among federal, state, and local governments; industry; and academia) is at the forefront of the effort to develop and manufacture these countermeasures. However, despite the PHEMCE's many successes, there are still serious challenges to overcome. Government-funded medical research is not always focused on countermeasures for the most serious potential threats, and it is difficult to engage pharmaceutical and biotechnology companies to develop and manufacture medical countermeasures that have a limited commercial market. At the request of the Secretary of the U.S. Department of Health and Human Services and the Assistant Secretary for Preparedness and Response, the IOM held a workshop February 22-24, 2010, to address challenges facing the PHEMCE. Workshop participants discussed federal policies and procedures affecting the research, development, and approval of medical countermeasures and explored opportunities to improve the process and protect Americans' safety and health."
Member of
Cataloging source
N$T
Dewey number
353.9/50973
Illustrations
illustrations
Index
no index present
LC call number
RA645.5
LC item number
.P83 2010eb
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
WA 295
http://library.link/vocab/relatedWorkOrContributorName
  • Wizemann, Theresa M
  • Stroud, Clare
  • Altevogt, Bruce M
  • Institute of Medicine (U.S.)
  • Institute of Medicine (U.S.)
Series statement
The national academies
http://library.link/vocab/subjectName
  • Emergency management
  • Public health
  • Emergency management
  • Disaster Medicine
  • Public Health
  • Emergency Medical Services
  • Program Development
  • Emergencies
  • Public Health
  • United States
  • POLITICAL SCIENCE
  • Emergency management
  • Emergency management
  • Public health
  • United States
Label
The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary, Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Instantiates
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop
Control code
650558721
Dimensions
unknown
Extent
1 online resource (xiv, 179 pages)
File format
unknown
Form of item
online
Isbn
9780309150255
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
color illustrations
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)650558721
Label
The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary, Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop
Control code
650558721
Dimensions
unknown
Extent
1 online resource (xiv, 179 pages)
File format
unknown
Form of item
online
Isbn
9780309150255
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
color illustrations
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)650558721

Library Locations

  • Ellis LibraryBorrow it
    1020 Lowry Street, Columbia, MO, 65201, US
    38.944491 -92.326012
  • Engineering Library & Technology CommonsBorrow it
    W2001 Lafferre Hall, Columbia, MO, 65211, US
    38.946102 -92.330125
  • Fisher Delta Research CenterBorrow it
    2-64 Agricultural Bldg, Columbia, MO, 65201, US
    38.958397 -92.303491
  • Geological Sciences LibraryBorrow it
    201 Geological Sciences, Columbia, MO, 65211, US
    38.947375 -92.329062
  • J. Otto Lottes Health Sciences LibraryBorrow it
    1 Hospital Dr, Columbia, MO, 65201, US
    38.939544 -92.328377
  • Journalism LibraryBorrow it
    102 Reynolds Jrnlism Institute, Columbia, MO, 65211, US
    38.947290 -92.328025
  • Mathematical Sciences LibraryBorrow it
    104 Ellis Library, Columbia, MO, 65201, US
    38.944377 -92.326537
  • University ArchivesBorrow it
    Columbia, MO, 65201, US
  • University Archives McAlester AnnexBorrow it
    703 Lewis Hall, Columbia, MO, 65211, US
    38.934630 -92.342290
  • University of Missouri Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65211, US
    38.919360 -92.291620
  • Zalk Veterinary Medical LibraryBorrow it
    Veterinary Medicine West, Columbia, MO, 65211, US
    38.941099 -92.317911
Processing Feedback ...